Koyfin Home > Directory > Health Care > Achillion Pharmaceuticals > EV / EBITDA (ltm)

Achillion Pharmaceuticals EV / EBITDA (ltm) Chart (ACHN)

Achillion Pharmaceuticals annual/quarterly EV / EBITDA (ltm) from 2018 to 2019. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Achillion Pharmaceuticals EV / EBITDA (ltm) for the quarter ending January 01, 2019 was 0.04 a -1,522.09% decrease of -0.63 year over year
  • Achillion Pharmaceuticals EV / EBITDA (ltm) for the last 12 months ending January 01, 2019 was 0.04 a -1,522.09% decrease of -0.63 year over year
  • Achillion Pharmaceuticals Annual EV / EBITDA (ltm) for 2019 was 0.04 a -84.56% decrease of -0.04 from 2018
  • Achillion Pharmaceuticals Annual EV / EBITDA (ltm) for 2019 was 0.08 a -435.26% decrease of -0.33 from 2018
  • Achillion Pharmaceuticals Annual EV / EBITDA (ltm) for 2019 was 0.41 a -64.20% decrease of -0.26 from 2018
Other Valuation Metrics:
  • Achillion Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $512m a -22.67% decrease of -116m year over year
  • Achillion Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 1.58 a -4.12% decrease of -0.06 year over year
  • Achillion Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $212m a -17.56% decrease of -37m year over year
View Chart On Koyfin

Quarterly ACHN EV / EBITDA (ltm) Data

01/20190.04
01/20190.08
01/20190.41
01/20190.67
01/20190.60
12/20180.78
12/20180.97
12/20181.09
12/20181.09
12/20181.27

Annual ACHN EV / EBITDA (ltm) Data

20190.04
20190.08
20190.41
20190.67
20190.60
20180.78
20180.97
20181.09
20181.09
20181.27